Hong Kong Archives -

China’s Henlius Biotech has pressed go on a $477 million initial public offering (IPO) on the Hong Kong

Henlius Biotech shrugs off Hong Kong disruption with $477M IPO bid

https://pharmaphorum.com/news/henlius-biotech-shrugs-off-hong-kong-disruption-with-477m-ipo-bid/

Biotechs taking an advantage of new Hong Kong exchange rules have been told to expect lower valuations, after

Hong Kong biotechs IPOs face lower valuations after Ascletis flop

https://pharmaphorum.com/news/hong-kong-biotech-ipos-face-lower-valuations-after-ascletis-flop/

Snapshot of clinical trial application processes in the region.

Regulatory timelines in the Asia-Pacific

https://pharmaphorum.com/views-and-analysis/regulatory-timelines-asia-pacific/

Hong Kong